LYONS GARY A — SEC insider filings

SEC reporting owner CIK 1123343. 44 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers all 44 filings on record, filed 2020-09-02 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NEUROCRINE BIOSCIENCES INC (NBIX)Director23—19 legs · 132,000 sh · $16,780,76736
Travere Therapeutics, Inc. (TVTX)Director9—8 legs · 58,000 sh · $1,550,50720
Brickell Biotech, Inc. (BBI)Director5——9
RIGEL PHARMACEUTICALS INC (RIGL)Director3——6
Eledon Pharmaceuticals, Inc. (ELDN)Director4——4

Insider filings — LYONS GARY A

FiledFormIssuerReported transactionsSource
2026-11-194NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 15,000 @ $53.64 · Sale (S): 1,200 @ $163.11 · Sale (S): 4,011 @ $163.94 · Sale (S): 5,689 @ $165.15 · Sale (S): 4,100 @ $165.90 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-08-194Travere Therapeutics, Inc. (TVTX)Option exercise (M): 5,000 @ $17.44 · Sale (S): 1,900 @ $62.53 · Sale (S): 2,600 @ $63.50 · Sale (S): 500 @ $64.16 · Option exercise (M): 5,000 @ $17.44 · Sale (S): 4,100 @ $63.27 · +3 moreEDGAR
2026-05-294NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 1,284 (derivative) @ $0 · Grant/award (A): 2,624 (derivative) @ $0EDGAR
2026-05-214Travere Therapeutics, Inc. (TVTX)Grant/award (A): 4,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2026-05-214NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 1,659 @ $0 · Option exercise (M): 1,659 (derivative) @ $0EDGAR
2026-04-164Travere Therapeutics, Inc. (TVTX)Option exercise (M): 8,000 @ $16.33 · Sale (S): 8,000 @ $41.07 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2025-12-044NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 15,000 @ $47.89 · Sale (S): 15,000 @ $152.61 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2025-05-224NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 1,435 @ $0 · Grant/award (A): 1,659 (derivative) @ $0 · Grant/award (A): 3,305 (derivative) @ $0 · Option exercise (M): 1,435 (derivative) @ $0EDGAR
2025-05-164Travere Therapeutics, Inc. (TVTX)Grant/award (A): 6,500 @ $0 · Grant/award (A): 19,500 (derivative) @ $0EDGAR
2024-10-044Travere Therapeutics, Inc. (TVTX)Option exercise (M): 40,000 @ $10.48 · Sale (S): 21,179 @ $14.35 · Sale (S): 18,821 @ $15.15 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2024-08-154NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 11,570 @ $42.76 · Sale (S): 11,570 @ $150.43 · Option exercise (M): 11,570 (derivative) @ $0EDGAR
2024-07-184NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 930 @ $42.76 · Sale (S): 930 @ $150.03 · Option exercise (M): 930 (derivative) @ $0EDGAR
2024-05-234NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 1,435 (derivative) @ $0 · Grant/award (A): 2,982 (derivative) @ $0EDGAR
2024-05-214NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 2,100 @ $0 · Option exercise (M): 2,100 (derivative) @ $0EDGAR
2024-05-164NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 12,500 @ $42.76 · Sale (S): 12,500 @ $135.63 · Option exercise (M): 12,500 (derivative) @ $42.76EDGAR
2024-05-104Travere Therapeutics, Inc. (TVTX)Grant/award (A): 6,500 @ $0 · Grant/award (A): 19,500 (derivative) @ $0EDGAR
2023-12-274NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 10,000 @ $130.04EDGAR
2023-12-054NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 5,000 @ $12.98 · Sale (S): 5,000 @ $116.77 · Option exercise (M): 5,000 (derivative) @ $12.98EDGAR
2023-09-144NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 5,000 @ $12.98 · Sale (S): 5,000 @ $115.02 · Option exercise (M): 5,000 (derivative) @ $12.98EDGAR
2023-09-064NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 5,000 @ $12.98 · Sale (S): 5,000 @ $110.06 · Option exercise (M): 5,000 (derivative) @ $12.98EDGAR
2023-07-124RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 25,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-05-194Travere Therapeutics, Inc. (TVTX)Grant/award (A): 4,500 @ $0 · Grant/award (A): 13,500 (derivative) @ $0EDGAR
2023-05-194NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 4,290 (derivative) @ $0 · Grant/award (A): 2,100 (derivative) @ $0EDGAR
2023-05-024Eledon Pharmaceuticals, Inc. (ELDN)Grant/award (A): 150,437 (derivative) @ $0EDGAR
2023-02-024Eledon Pharmaceuticals, Inc. (ELDN)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-11-024NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 15,000 @ $12.71 · Sale (S): 15,000 @ $114.76 · Option exercise (M): 15,000 (derivative) @ $12.71EDGAR
2022-10-054NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 5,000 @ $110.54EDGAR
2022-05-234RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 25,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2022-05-204NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 9,724 (derivative) @ $0EDGAR
2022-05-174Brickell Biotech, Inc. (BBI)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2022-05-124Travere Therapeutics, Inc. (TVTX)Grant/award (A): 3,000 @ $0 · Grant/award (A): 9,000 (derivative) @ $0EDGAR
2022-04-274NEUROCRINE BIOSCIENCES INC (NBIX)Option exercise (M): 15,000 @ $6.66 · Sale (S): 15,000 @ $92.76 · Option exercise (M): 15,000 (derivative) @ $6.66EDGAR
2022-02-024Eledon Pharmaceuticals, Inc. (ELDN)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-10-124NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 5,000 @ $105.06EDGAR
2021-06-144Brickell Biotech, Inc. (BBI)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-144NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 10,000 @ $100.27EDGAR
2021-05-214RIGEL PHARMACEUTICALS INC (RIGL)Grant/award (A): 25,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2021-05-204NEUROCRINE BIOSCIENCES INC (NBIX)Grant/award (A): 8,833 (derivative) @ $0EDGAR
2021-05-184Travere Therapeutics, Inc. (TVTX)Grant/award (A): 3,000 @ $0 · Grant/award (A): 9,000 (derivative) @ $0EDGAR
2021-01-274NEUROCRINE BIOSCIENCES INC (NBIX)Sale (S): 1,600 @ $120.03 · Sale (S): 400 @ $120EDGAR
2021-01-054Brickell Biotech, Inc. (BBI)Tax withholding (F): 5,967 @ $0.78EDGAR
2020-09-174Brickell Biotech, Inc. (BBI)Grant/award (A): 11,934 @ $0.81 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2020-09-154Novus Therapeutics, Inc. (NVUS)Grant/award (A): 1,167.21 (derivative) @ $0EDGAR
2020-09-024Brickell Biotech, Inc. (BBI)Option exercise (M): 692 · Tax withholding (F): 346 @ $0.94 · Tax withholding (F): 8,631 @ $0.94 · Option exercise (M): 692 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1123343 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs